Finance

Lists
Why is CRVO up 3.14%?
Dive Deeper
CRVO:NASDAQ
CervoMed Inc
$3.28
+3.14%
(+0.100) 1D
Oct 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRVO...
Open
$3.15
High
$3.31
Low
$3.13
Mkt. cap
49.59M
Avg. vol.
208.83K
Volume
329.36K
52-wk high
$10.00
52-wk low
$2.15
EPS
-$3.21
Beta
-0.75
Shares outstanding
15.12M
No. of employees
15
Open
$3.15
High
$3.31
Low
$3.13
Mkt. cap
49.59M
Avg. vol.
208.83K
Volume
329.36K
52-wk high
$10.00
52-wk low
$2.15
EPS
-$3.21
Beta
-0.75
Shares outstanding
15.12M
No. of employees
15
News stories
From web sources and news partners
About CervoMed Inc
CEO-
Employees15
Founded1995
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitecervomed.com
Analyst ratings
Based on 4 analysts giving stock ratings to CRVO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRVO in the last 3 months.
Highest
Current $3.28
$25.00 (+662.20%)
Average
$15.50 (+372.56%)
Lowest
$7.00 (+113.41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$25.00
+662.2%
10/05/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$7.00
+113.4%
10/01/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$18.00
+448.8%
09/29/2026
Boris Peaker
JonesTrading
Buy
Maintained
$12.00
+265.9%
09/28/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$21.00
+540.2%
05/17/2026
Soumit Roy
JonesTrading
Buy
Maintained
$20.00
+509.8%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
322.57K
8.73K
-
-
Cost of goods sold
6.04M
5.83M
5.14M
4.32M
Cost of revenue
6.04M
5.83M
5.14M
4.32M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.33M
2.51M
2.98M
2.36M
Operating expense
2.33M
2.51M
2.98M
2.36M
Total operating expenses
8.37M
8.34M
8.11M
6.68M
Operating income
-8.04M
-8.33M
-8.11M
-6.68M
Other non operating income
-1.23K
3.29K
-1.02K
2.00K
EBT including unusual items
-7.73M
-8.09M
-7.96M
-6.57M
EBT excluding unusual items
-7.73M
-8.09M
-7.96M
-6.57M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.73M
-8.09M
-7.96M
-6.57M
Net profit margin
-2,395.34%
-92,680.38%
-
-
Earnings per share
-0.84
-0.88
-0.86
-0.64
Interest and investment income
318.79K
240.94K
147.39K
104.90K
Interest expense
-
-
-
-
Net interest expenses
318.79K
240.94K
147.39K
104.90K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps